Not Medicare Enrolled

Dr. Dania Wierzbicki, MD

Allergy & Immunology · Dallas, TX
5499 GLEN LAKES DR, Dallas, TX 75231
2146911330
Registered in NPPES since 2006
NPI: 1841222346 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wierzbicki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wierzbicki? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wierzbicki

Dr. Dania Wierzbicki is an allergy & immunology specialist in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Wierzbicki received a total of $9,507 from 38 pharmaceutical and/or device companies across 452 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wierzbicki is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $9,507 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,507
Total received (2018-2024)
Avg $1,358/year across 7 years
Top 33% in TX for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
452
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,476
2023
$1,301
2022
$1,298
2021
$1,546
2020
$1,277
2019
$1,306
2018
$1,303

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$301
Regeneron Healthcare Solutions, Inc.
$292
GENZYME CORPORATION
$158
CSL Behring
$128
Genentech USA, Inc.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$111
Grifols USA, LLC
$96
Novartis Pharmaceuticals Corporation
$58
GlaxoSmithKline, LLC.
$47
Incyte Corporation
$40
Hikma Pharmaceuticals USA
$39
HOSPIRA, INC.
$35
kaleo, Inc.
$26
ALK-Abello, Inc
$24
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,059
Regeneron Healthcare Solutions, Inc.
$1,160
GlaxoSmithKline, LLC.
$921
ALK-Abello, Inc
$651
GENZYME CORPORATION
$549
CSL Behring
$436
Takeda Pharmaceuticals U.S.A., Inc.
$364
Covis Pharma GmBH
$344
Teva Pharmaceuticals USA, Inc.
$293
Novartis Pharmaceuticals Corporation
$266
kaleo, Inc.
$255
Pharming Healthcare, Inc.
$250
Grifols USA, LLC
$240
Octapharma USA, Inc.
$214
Genentech USA, Inc.
$158
Shire North American Group Inc
$151
PFIZER INC.
$149
Covis Pharma B.V.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Covis Pharma GmbH
$115
LEO Pharma Inc.
$80
Amgen Inc.
$80
Incyte Corporation
$73
BioCryst US Sales Co., LLC
$58
Hikma Pharmaceuticals USA
$54
Blueprint Medicines Corporation
$38
HOSPIRA, INC.
$35
Optinose US, Inc.
$34
OptiNose US, Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$25
AbbVie Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
BioCryst Pharmaceuticals, Inc.
$22
ABBVIE INC.
$19
Boston Scientific Corporation
$18
Mylan Specialty L.P.
$17
Sunovion Pharmaceuticals Inc.
$15
Almirall LLC
$12
Top 3 companies account for 43.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ALVESCO · AUVI-Q · AYVAKIT · AirDuo Digihaler · BREO · BREZTRI · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · FIRAZYR · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · Otiprio · PRE-PEN · PREVNAR 20 · Privigen · ProAir Digihaler · QVAR · RINVOQ · RUCONEST · Ryaltris · SHINGRIX · SPIRIVA · SPIRIVA RESPIMAT · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · Utibron · VERDESO · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Dallas?
Compare allergy & immunologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
66
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wierzbicki is an allergy & immunology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Wierzbicki receive payments from pharmaceutical companies?
Yes. Dr. Wierzbicki received a total of $9,507 from 38 companies across 452 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Wierzbicki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Allergy & Immunologists in Dallas
Browse allergy & immunologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunologists in TX
Allergy & immunologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunologists in TX
Which TX allergy & immunologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →